Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial (Q39704999)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial |
scientific article |
Statements
1 reference
Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial (English)
1 reference
1 reference
Paolo A Ascierto
1 reference
Jeffry Evans
1 reference
Scott J Antonia
1 reference
José A López-Martin
1 reference
Johanna Bendell
1 reference
Patrick A Ott
1 reference
Matthew Taylor
1 reference
Joseph Paul Eder
1 reference
Dirk Jäger
1 reference
M Catherine Pietanza
1 reference
Dung T Le
1 reference
Michael A Morse
1 reference
Leora Horn
1 reference
Asim Amin
1 reference
Rathi N Pillai
1 reference
Ian Chau
1 reference
Petri Bono
1 reference
Akin Atmaca
1 reference
Padmanee Sharma
1 reference
Christopher T Harbison
1 reference
Chen-Sheng Lin
1 reference
Olaf Christensen
1 reference
Emiliano Calvo
1 reference
3 June 2016
1 reference
1 reference
17
1 reference
7
1 reference
883-895
1 reference
Identifiers
1 reference
1 reference